首页 | 本学科首页   官方微博 | 高级检索  
     


PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics
Authors:Maria Currás-Freixes  Elena Piñeiro-Yañez  Cristina Montero-Conde  María Apellániz-Ruiz  Bruna Calsina  Veronika Mancikova  Laura Remacha  Susan Richter  Tonino Ercolino  Natalie Rogowski-Lehmann  Timo Deutschbein  María Calatayud  Sonsoles Guadalix  Cristina Álvarez-Escolá  Cristina Lamas  Javier Aller  Julia Sastre-Marcos  Conxi Lázaro  Mercedes Robledo
Affiliation:1. Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre, Madrid, Spain;2. Translational Bioinformatics Unit, Spanish National Cancer Research Centre, Madrid, Spain;3. Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universitat Dresden, Dresden, Germany;4. Department of Experimental and Clinical Biomedical Sciences Mario Serio, University of Florence and Istituto Toscano Tumori, Florence, Italy;5. Department of Internal Medicine IV Campus Innenstadt, University-Hospital, Ludwig-Maximilians-University of Munich, Munich, Germany;6. Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital, University of Würzburg, Würzburg, Germany;7. Department of Endocrinology and Nutrition Service, University Hospital 12 de Octubre, Madrid, Spain;11. Department of Endocrinology, University Hospital La Paz, Madrid, Spain;12. Department of Endocrinology, Albacete University Hospital Complex, Albacete, Spain;8. Department of Endocrinology, University Hospital Puerta de Hierro, Madrid, Spain;9. Department of Endocrinology, Virgen de la Salud Hospital–Toledo Hospital Complex, Toledo, Spain;10. Molecular Diagnostics Units of the Hereditary Cancer Program at the Catalan Institute of Oncology, Barcelona, Spain;71. Department of Endocrinology, University of Navarra Clinic, Navarra, Spain;112. Department of Pediatrics and Clinical Genetics Unit, University of Navarra Clinic, Navarra, Spain;123. Department of Endocrinology, Reina Sofia University Hospital, Murcia, Spain;84. High Risk and Cancer Prevention Group, Medical Oncology Department, Vall d''Hebron University Hospital and Vall d''Hebron Institute of Oncology, Barcelona, Spain;95. Department of Endocrinology, San Carlos (Clínico) Hospital, Madrid, Spain;106. Department of Molecular Oncology, Central University Hospital of Asturias and University Institute of Oncology of Asturias, University of Oviedo, Oviedo, Spain;77. Department of Endocrinology and Nutrition, University Hospital Arnau de Vilanova, IRBLLEIDA, Lleida, Spain;1111. Department of Pathology, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain;1212. Biomedical Research Networking Center on Rare Diseases (CIBERER), Madrid, Spain;88. 1st Department of Medicine, University Medical Center Schleswig-Holstein, Campus Lübeck, Lübeck, Germany;99. Department of Endocrinology, Department of Medical and Surgical Sciences University of Padova, Padova, Italy;1010. Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, Maryland;771. Department of Pathology, Erasmus University Medical Center, Rotterdam, the Netherlands;11112. Department of Pathology, Reinier de Graaf Hospital, Delft, the Netherlands;12123. Department of Endocrinology, Centre Hospitalier Universitaire de Liège, Liège, Belgium;884. Department of Medicine III, University Hospital Carl Gustav Carus, Dresden, Germany
Abstract:
Keywords:Address correspondence to Mercedes Robledo   Ph.D.   Hereditary Endocrine Cancer Group Leader   Centro Nacional de Investigaciones Oncológicas   C/Melchor Fernández Almagro 3   28029 Madrid   Spain.
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号